Li Zhu Selected Research

Cisplatin (Platino)

6/2023	Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin.
5/2023	CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells.
4/2023	A Photoactivated Ru (II) Polypyridine Complex Induced Oncotic Necrosis of A549 Cells by Activating Oxidative Phosphorylation and Inhibiting DNA Synthesis as Revealed by Quantitative Proteomics.
4/2023	METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
6/2021	YY1-Induced lncRNA PART1 Enhanced Resistance of Ovarian Cancer Cells to Cisplatin by Regulating miR-512-3p/CHRAC1 Axis.
1/2021	Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.
6/2019	Development of β-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts.
11/2017	[Chemical constituents of liquid culture of symbiotic Chaetomium globosum ML-4 of oyster and their in vitro antitumor activity].
8/2017	Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
10/2016	Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Zhu Research Topics

Disease

211	Neoplasms (Cancer) 05/2024 - 02/2003
80	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2004
66	Inflammation (Inflammations) 06/2024 - 05/2005
49	Hypoxia (Hypoxemia) 10/2023 - 02/2000
46	Infections 04/2024 - 12/2005
35	Neoplasm Metastasis (Metastasis) 09/2023 - 06/2004
33	IGA Glomerulonephritis (IGA Nephropathy) 01/2024 - 08/2008
26	Fibrosis (Cirrhosis) 06/2024 - 12/2004
24	Atherosclerosis 05/2024 - 07/2009
22	Obesity 05/2024 - 01/2012
22	Lung Neoplasms (Lung Cancer) 02/2024 - 03/2003
19	Ischemia 06/2023 - 02/2000
19	Thrombosis (Thrombus) 11/2022 - 01/2006
18	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2007
16	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 07/2004
16	Insulin Resistance 12/2023 - 08/2008
15	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 06/2003
15	COVID-19 01/2024 - 01/2020
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 10/2014
14	Squamous Cell Carcinoma of Head and Neck 04/2024 - 10/2005
14	Hypertension (High Blood Pressure) 01/2024 - 01/2014
14	Carcinoma (Carcinomatosis) 01/2023 - 11/2003
13	Carcinogenesis 03/2024 - 01/2004
13	Stroke (Strokes) 01/2024 - 01/2013
13	Reperfusion Injury 01/2022 - 01/2007
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 02/2003
12	Heart Failure 04/2024 - 01/2012
12	Proteinuria 01/2024 - 12/2009
12	Lymphatic Metastasis 10/2023 - 12/2006
12	Body Weight (Weight, Body) 04/2023 - 12/2011
11	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2005
11	Atherosclerotic Plaque (Atheroma) 05/2024 - 07/2008
11	Atrial Fibrillation 04/2024 - 01/2015
11	Melanoma (Melanoma, Malignant) 03/2024 - 08/2013
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 02/2005
10	Coronary Disease (Coronary Heart Disease) 12/2023 - 01/2015
10	Leukemia 12/2021 - 09/2008
10	Type 2 Diabetes Mellitus (MODY) 12/2021 - 10/2010
9	Liver Cirrhosis (Hepatic Cirrhosis) 06/2024 - 07/2018
9	Myocardial Infarction 04/2024 - 01/2013
9	Ischemic Stroke 01/2024 - 11/2012
8	Multiple Myeloma 01/2024 - 01/2018
8	Pain (Aches) 12/2023 - 11/2006
8	Non-alcoholic Fatty Liver Disease 12/2023 - 02/2016
8	Ovarian Neoplasms (Ovarian Cancer) 06/2023 - 10/2009
8	Pneumonia (Pneumonitis) 01/2023 - 07/2011
8	Diabetes Mellitus 01/2023 - 01/2013

Drug/Important Bio-Agent (IBA)

96	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2000
58	Biomarkers (Surrogate Marker)IBA 06/2024 - 12/2003
38	Messenger RNA (mRNA)IBA 05/2023 - 01/2004
34	MicroRNAs (MicroRNA)IBA 05/2023 - 02/2011
25	CytokinesIBA 01/2024 - 06/2004
22	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 12/2005
21	VaccinesIBA 05/2024 - 07/2005
20	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 11/2004
19	Estrogen ReceptorsIBA 02/2023 - 10/2015
18	LipidsIBA 05/2024 - 07/2009
18	Oxygen (Dioxygen)IBA 01/2024 - 11/2004
18	Immunoglobulin A (IgA)IBA 12/2023 - 10/2007
18	LigandsIBA 01/2023 - 12/2003
17	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 05/2005
16	Hormones (Hormone)IBA 04/2023 - 08/2008
16	Long Noncoding RNAIBA 01/2023 - 01/2015
15	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 10/2005
14	Therapeutic UsesIBA 01/2024 - 09/2006
13	Indicators and Reagents (Reagents)IBA 05/2024 - 06/2011
13	Peptides (Polypeptides)IBA 12/2023 - 03/2003
12	EnzymesIBA 01/2024 - 10/2010
12	human ERBB2 proteinIBA 02/2023 - 06/2017
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 02/2000
12	Insulin (Novolin)FDA Link 10/2022 - 06/2003
11	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2019
11	Interleukin-6 (Interleukin 6)IBA 03/2024 - 12/2008
11	AntigensIBA 09/2023 - 05/2017
11	IronIBA 02/2023 - 03/2006
11	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2009
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 01/2006
11	Transcription Factors (Transcription Factor)IBA 04/2022 - 06/2005
10	Circular RNAIBA 06/2024 - 01/2018
10	Complement System Proteins (Complement)IBA 01/2024 - 09/2015
10	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
10	Phosphotransferases (Kinase)IBA 01/2023 - 09/2007
9	AlbuminsIBA 12/2023 - 02/2000
9	Phenobarbital (Luminal)FDA Link 02/2023 - 01/2014
9	AntibodiesIBA 01/2022 - 08/2004
8	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 01/2009
8	CollagenIBA 03/2024 - 05/2002
8	Epidermal Growth Factor (EGF)IBA 03/2024 - 12/2015
8	AntioxidantsIBA 02/2024 - 02/2005
8	Complement Factor H (Factor H)IBA 12/2023 - 05/2015
8	LipopolysaccharidesIBA 12/2023 - 01/2017
8	Amyloid (Amyloid Fibrils)IBA 09/2023 - 11/2012
8	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2014

Therapy/Procedure

101	Therapeutics 05/2024 - 02/2004
44	Drug Therapy (Chemotherapy) 05/2024 - 10/2005
25	Radiotherapy 10/2023 - 12/2006
17	Neoadjuvant Therapy 10/2023 - 07/2004
14	Immunotherapy 10/2023 - 11/2003
13	Adjuvant Chemotherapy 06/2022 - 09/2012
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2022 - 11/2012